Literature DB >> 29506553

Correction to: Protective and therapeutic role of 2-carbacyclic phosphatidic acid in demyelinating disease.

Shinji Yamamoto1, Kota Yamashina1, Masaki Ishikawa1, Mari Gotoh2, Sosuke Yagishita1, Kensuke Iwasa1, Kei Maruyama1, Kimiko Murakami-Murofushi2, Keisuke Yoshikawa3.   

Abstract

After publication of the article [1], it was brought to our attention that an acknowledgement was missing from the original version.

Entities:  

Year:  2018        PMID: 29506553      PMCID: PMC5839018          DOI: 10.1186/s12974-018-1104-x

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


Correction

After publication of the article [1], it was brought to our attention that an acknowledgement was missing from the original version. The authors would also like to include “We appreciate that Dr. Yoshibumi Shimizu at Ochanomizu University for sharing with us his preliminary experimental results about 2ccPA in the mouse brain following intraperitoneal administration”.
  1 in total

1.  Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.

Authors:  Shinji Yamamoto; Kota Yamashina; Masaki Ishikawa; Mari Gotoh; Sosuke Yagishita; Kensuke Iwasa; Kei Maruyama; Kimiko Murakami-Murofushi; Keisuke Yoshikawa
Journal:  J Neuroinflammation       Date:  2017-07-21       Impact factor: 8.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.